Tryp Therapeutics Inc (OP: TRYPF )
0.0570 UNCHANGED Streaming Delayed Price Updated: 3:16 PM EDT, Mar 27, 2023 Add to My Watchlist
All News about Tryp Therapeutics Inc
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
January 10, 2023
Guess Which East Coast State Is Now Discussing Legalizing Psychedelics? Decriminalizing psychedelics is one thing, but fully legalizing them is another. That's currently a measure before New York's...
Tryp Therapeutics to Webcast Live at VirtualInvestorConferences.com on Thursday, December 15
December 12, 2022
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
Via Globe NewsWire
The World Intellectual Property Organization (WIPO) has published clinical-stage biopharma Tryp Therapeutics Inc. (OTCQB: TRYPF)’s international patent application for the intravenous (IV)...
Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?
September 26, 2022
Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. (OTCQB: TRYPF) filed two provisional patent applications - one for psilocybin therapy for fibromyalgia and another expanding...
In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its...
Could Magic Mushrooms Be A Solution For Overeating? New Clinical Trial Intends To Find Out
April 28, 2022
Psilocybin, the active ingredient in “magic mushrooms,” could be part of the solution for people struggling with binge eating disorder, a condition characterized by recurring episodes of eating large...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following